Staff Publications

  • external user (warningwarning)
  • Log in as
  • language uk
Record number 536096
Title Recognition of microbial viability via TLR8 drives TFH cell differentiation and vaccine responses
Author(s) Ugolini, Matteo; Gerhard, Jenny; Burkert, Sanne; Jensen, Kristoffer Jarlov; Georg, Philipp; Ebner, Friederike; Volkers, Sarah M.; Thada, Shruthi; Dietert, Kristina; Bauer, Laura; Schäfer, Alexander; Helbig, Elisa T.; Opitz, Bastian; Kurth, Florian; Sur, Saubashya; Dittrich, Nickel; Gaddam, Sumanlatha; Conrad, Melanie L.; Benn, Christine S.; Blohm, Ulrike; Gruber, Achim D.; Hutloff, Andreas; Hartmann, Susanne; Boekschoten, Mark V.; Müller, Michael; Jungersen, Gregers; Schumann, Ralf R.; Suttorp, Norbert; Sander, Leif E.
Source Nature Reviews. Immunology 19 (2018)4. - ISSN 1529-2908 - p. 386 - 396.
Department(s) VLAG
Chair Nutrition Metabolism and Genomics
Publication type Refereed Article in a scientific journal
Publication year 2018
Abstract Live attenuated vaccines are generally highly efficacious and often superior to inactivated vaccines, yet the underlying mechanisms of this remain largely unclear. Here we identify recognition of microbial viability as a potent stimulus for follicular helper T cell (TFH cell) differentiation and vaccine responses. Antigen-presenting cells (APCs) distinguished viable bacteria from dead bacteria through Toll-like receptor 8 (TLR8)-dependent detection of bacterial RNA. In contrast to dead bacteria and other TLR ligands, live bacteria, bacterial RNA and synthetic TLR8 agonists induced a specific cytokine profile in human and porcine APCs, thereby promoting TFH cell differentiation. In domestic pigs, immunization with a live bacterial vaccine induced robust TFH cell and antibody responses, but immunization with its heat-killed counterpart did not. Finally, a hypermorphic TLR8 polymorphism was associated with protective immunity elicited by vaccination with bacillus Calmette-Guérin (BCG) in a human cohort. We have thus identified TLR8 as an important driver of TFH cell differentiation and a promising target for TFH cell-skewing vaccine adjuvants.
There are no comments yet. You can post the first one!
Post a comment
Please log in to use this service. Login as Wageningen University & Research user or guest user in upper right hand corner of this page.